Enhanced safety focus is shaping the Synthetic Cannabinoids Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Synthetic Cannabinoids Market Projected To Become By 2030 Based On Its 2026 Valuation?

The synthetic cannabinoids market size has experienced rapid expansion in recent years. This market is projected to expand from $2.2 billion in 2025 to $2.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. Historically, this growth can be ascribed to several factors, including the limitations of plant-derived cannabinoids, the increasing demand for potency control, specific pharmaceutical research needs, the rise in pain management therapies, and the attainment of regulatory approvals in certain regions.

The synthetic cannabinoids market is projected to undergo substantial expansion in the coming years. Its valuation is set to reach $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This anticipated growth during the forecast period is primarily driven by factors such as the broadening of medical cannabis applications, the rise of controlled cannabinoid therapies, the increasing need for precision dosing, the scalability of synthetic active pharmaceutical ingredients (APIs), and increased pharmaceutical research and development investments. Furthermore, key trends expected during this period involve the wider availability of pharmaceutical-grade cannabinoids, enhanced research applications of synthetic cannabinoids, a surge in the requirement for high-purity formulations, a move towards regulated medical uses, and progress in controlled synthesis methodologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Primary Drivers Are Shaping The Development Of The Synthetic Cannabinoids Market?

The increasing need for treatments for neurological disorders is anticipated to propel the expansion of the synthetic cannabinoids market going forward. Neurological disorders are diseases affecting the brain, spinal cord, and nerves that can impair movement, sensation, cognition, or overall body function. The growing prevalence of neurological disorders is primarily due to the global aging population, as conditions such as Alzheimer’s become more common with advancing age owing to brain aging and accumulated cellular damage. Synthetic cannabinoids specifically target cannabinoid receptors in the brain, aiding in the regulation of neurotransmitter activity and potentially mitigating symptoms linked to neurological disorders. For example, in September 2024, data from the European Brain Council, a health organization based in Belgium, indicated that 7 million people in Europe currently live with Alzheimer’s disease, a figure expected to reach 14 million by 2030 due to an aging population, thereby posing a substantial global public health challenge. Consequently, the rising demand for neurological disorder treatments is driving the growth of the synthetic cannabinoids market.

What Segment Groups Are Identified Within The Synthetic Cannabinoids Market?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

What Trends Are Advancing Progress In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are concentrating on creating safer, high-quality products, such as novel psychoactive substances, to mitigate health risks and bolster their competitive standing. Novel psychoactive substances refer to laboratory-engineered designer drugs that replicate the effects of conventional illicit substances but utilize altered chemical structures to bypass detection and regulation. For instance, in December 2023, Quest Diagnostics Inc., a US-based healthcare company, unveiled a new 88-compound Novel Psychoactive Substance (NPS) Test Panel to aid in more precisely identifying a broad spectrum of synthetic cannabinoids and other designer drugs. This advanced mass-spectrometry-based test offers clearer identification of emerging synthetic cannabinoids, enabling healthcare providers to better comprehend patient exposure and refine treatment decisions. The introduction of such sophisticated testing solutions emphasizes the increasing necessity for reliable monitoring tools as synthetic cannabinoids continue to evolve, ensuring enhanced safety, transparency, and regulatory compliance across the market.

Which Companies Hold Significant Positions In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Read the full synthetic cannabinoids market report here:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

How Does The Synthetic Cannabinoids Market Perform Across Major Global Regions?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Synthetic Cannabinoids Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2026, By The Business Research Company

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795